MicroStrategy Inc. (NASDAQ:MSTR) has officially rebranded as Strategy, reflecting its sharpened focus on Bitcoin read more

Bill Ackman shared choice comments on UnitedHealth Group on his social media account before deleting his posts. Here’s a look at what the hedge funder said. read more

Crypto analyst Michaёl van de Poppe urges investors to hold their crypto assets, emphasizing that Bitcoin (CRYPTO: BTC) is fairly valued while altcoins remain heavily undervalued. read more

Latest Ratings for CVRX Date Firm Action From To Jul 2021 William Blair Initiates Coverage On Outperform Jul 2021 Canaccord Genuity Initiates Coverage On Buy Jul 2021 JP Morgan Initiates Coverage On Overweight View More Analyst Ratings for CVRX View the Latest Analyst Ratings read more

Latest Ratings for INTA Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Jan 2022 Piper Sandler Maintains Overweight Nov 2021 Piper Sandler Maintains Overweight View More Analyst Ratings for INTA View the Latest Analyst Ratings read more

Latest Ratings for PNR Date Firm Action From To Mar 2022 Mizuho Upgrades Underperform Neutral Feb 2022 Morgan Stanley Maintains Underweight Jan 2022 Morgan Stanley Maintains Underweight View More Analyst Ratings for PNR View the Latest Analyst Ratings read more

Eli Lilly will announce Q4 2024 results, with analysts estimating $13.7 billion in sales and $4.94 EPS, alongside a revenue growth outlook for 2024. Latest Ratings for LLY Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 Mizuho Maintains Buy Jan 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for…

read more

read more

read more